Related Experiment Video
Updated: Jun 9, 2026

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Clinical Profile and Risk Factors for Severe Disease in 402 Children Hospitalized with SARS-CoV-2 from India:
Kana Ram Jat1, Jhuma Sankar1, Rashmi Ranjan Das2
1Department of Pediatrics, All India Institute of Medical Sciences, New Delhi 110029, India.
Insights
This study describes the clinical features and risk factors for severe coronavirus disease (COVID-19) in Indian children. High urea and low total serum protein were identified as novel risk factors for severe COVID-19 in pediatric patients.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Limited multicentric studies on pediatric COVID-19 exist from developing nations.
- Understanding the clinical profile and risk factors in Indian children is crucial.
Purpose of the Study:
- To describe the clinical characteristics of children hospitalized with COVID-19 in India.
- To identify risk factors associated with severe disease in this pediatric population.
Main Methods:
- Retrospective multicentric study involving 402 children in India.
- Data collected included demographics, clinical features, laboratory results, and outcomes.
- Analysis focused on identifying factors linked to moderate to severe COVID-19.
Main Results:
- Fever was the most common symptom; 44% had comorbidities.
- The majority were asymptomatic or mildly symptomatic; 9.7% had moderate-severe disease, and 3.2% died.
- Laboratory abnormalities included lymphopenia, thrombocytopenia, transaminitis, and elevated inflammatory markers; high urea and low total serum protein were associated with severe disease.
Conclusions:
- Fever is the most common symptom in pediatric COVID-19 in India.
- Novel risk factors for severe disease, including high urea and low total serum protein, were identified.
- Most children experienced mild or no symptoms, but specific factors indicate a risk for severe outcomes.
Introduction:
There is a lack of large multicentric studies in children with COVID-19 from developing countries. We aimed to describe the clinical profile and risk factors for severe disease in children hospitalized with COVID-19 from India.
Methods:
In this multicentric retrospective study, we retrieved data related to demographic details, clinical features, including the severity of disease, laboratory investigations and outcome.
Results:
We included 402 children with a median (IQR) age of 7 (2-11) years. Fever was the most common symptom, present in 38.2% of children. About 44% had underlying comorbidity. The majority were asymptomatic (144, 35.8%) or mildly symptomatic (219, 54.5%). There were 39 (9.7%) moderate-severe cases and 13 (3.2%) deaths. The laboratory abnormalities included lymphopenia 25.4%, thrombocytopenia 22.1%, transaminitis 26.4%, low total serum protein 34.7%, low serum albumin 37.9% and low alkaline phosphatase 40%. Out of those who were tested, raised inflammatory markers were ferritin 58.9% (56/95), c-reactive protein 33.3% (41/123), procalcitonin 53.5% (46/86) and interleukin-6 (IL-6) 76%. The presence of fever, rash, vomiting, underlying comorbidity, increased total leucocyte count, thrombocytopenia, high urea, low total serum protein and raised c-reactive protein was factors associated with moderate to severe disease.
Conclusion:
Fever was the commonest symptom. We identified additional laboratory abnormalities, namely lymphopenia, low total serum protein and albumin and low alkaline phosphatase. The majority of the children were asymptomatic or mildly symptomatic. We found high urea and low total serum protein as risk factors for moderate to severe disease for the first time.
More Related Videos
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pneumonia II: Pathophysiology
Viral Meningitis
Cytomegalovirus Disease
Coronavirus
Respiratory Syncytial Virus Disease

